Originally published by our sister publication Specialty Pharmacy Continuum
A managed care outreach program that underscored the financial benefits of switching patients from branded to generic multiple sclerosis (MS) drugs has yielded more than $10 million in savings.
Pharmacists with the HighTouchRx program, operated by Prime Therapeutics/Magellan Rx Management, reviewed claims data from 807 patients taking brand-name MS drugs in 2023. Their outreach to providers resulted in 141